Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alytas Therapeutics GmbH
Jena, Thuringia, Germanyxlifesciences.ch ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Alytas Therapeutics develops antibody-based therapies targeting hypertrophic adipocytes for the treatment of morbid obesity and associated metabolic disorders. Their lead programs are in preclinical development; proof-of-concept has been demonstrated in vitro and in vivo. The company also outlicensed some antibodies for senolytic applications.[1][2][4][5][7][9]
- Therapeutic areas
- OtherEndocrinologyMetabolic Disorders
- Modalities
- Monoclonal antibodies (mAbs)Immunotherapies
- Industry
- Biotech
02
Partnerships
Velabs Therapeutics/VERAXA Biotech – strategic R&D partnership on functional antibody discovery and co-development/licensing agreements for both obesity immunotherapy and senolytic indications[3][5][9]CureDiab Metabolic Research – research collaboration on functional characterization of antibodies targeting adipose tissue metabolism[1][7]
Beyond the preview
Go deeper on Alytas Therapeutics GmbH.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Alytas Therapeutics GmbH.